A Phase II Trial of Tiragolumab with Carboplatin, Pemetrexed, And Atezolizumab in Non-Squamous NSCLC and Brain Metastases

被引：0
|
作者：
Schluger, B. [1 ]
Burns, T. F. [1 ]
Wang, H. [1 ]
Petro, D. P. [1 ]
Ohr, J. [1 ]
Burton, S. A. [1 ]
McCall, N. [1 ]
Choi, S. [1 ]
Abdullah, K. G. [1 ]
Niranjan, A. [1 ]
Hadjipanayis, C. G. [1 ]
Villaruz, L. C. [1 ]
机构：
[1] Univ Pittsburgh, Pittsburgh, PA USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 10期
关键词：
Tiragolumab; NSCLC; Metastases;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P4.11D.10
引用
收藏
页码：S393 / S394
页数：2
相关论文
共 50 条
  • [1] A Phase II Study of Pemetrexed plus Carboplatin Followed by Maintenance Pemetrexed in Elderly Patients with Advanced Non-Squamous NSCLC
    Tamiya, Motohiro
    Tamiya, Akihiro
    Kaneda, Hiroyasu
    Nakagawa, Kazuhiko
    Goto, Koichi
    Yoh, Kiyotaka
    Okamoto, Hiroaki
    Shimokawa, Tsuneo
    Tanaka, Hiroshi
    Abe, Tetsuya
    Daga, Haruko
    Takeda, Koji
    Hirashima, Tomonori
    Atagi, Shinji
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S316 - S316
  • [2] Phase II study of carboplatin/ pemetrexed/bevacizumab for non-squamous NSCLC with carcinomatous pleuritis (NEJ013A)
    Miyauchi, Eisaku
    Usui, Kazuhiro
    Sugawara, Shunichi
    Nishitsuji, Masaru
    Fujita, Yuka
    Mouri, Atsuto
    Watanabe, Hiroshi
    Sakai, Hiroshi
    Kinoshita, Ichiro
    Hagiwara, Koichi
    ANNALS OF ONCOLOGY, 2016, 27
  • [3] Phase II study of carboplatin/pemetrexed/bevacizumab followed by bev/erlotinib maintenance for non-squamous NSCLC with WT EGFR
    Watanabe, Masahiro
    Takashina, Taichi
    Asahina, Hajime
    Amano, Toraji
    Yokouchi, Hiroshi
    Takamura, Kei
    Harada, Toshiyuki
    Honjo, Osamu
    Morikawa, Naoto
    Kinoshita, Ichiro
    ANNALS OF ONCOLOGY, 2015, 26 : 91 - 92
  • [4] Phase I/II Study of Erlotinib, Carboplatin, Pemetrexed and Bevacizumab for Advanced Non-Squamous NSCLC Harboring EGFR Mutation
    Yokoi, Takashi
    Kurata, Takayasu
    Torii, Yoshitaro
    Satsutani, Naoko
    Kibata, Kayoko
    Niki, Maiko
    Nomura, Shosaku
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1219 - S1219
  • [5] Phase II Trial of Carboplatin, Pemetrexed, Bevacizumab in Advanced non-Small Cell (non-Squamous) Lung Cancer
    Guarino, Michael J.
    Masters, Gregory A.
    Biggs, David D.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S698 - S698
  • [6] Updated Phase I Results of Carboplatin, Pemetrexed and Exemestane in Postmenopausal Women with Metastatic Non-Squamous NSCLC
    Young, P.
    Marquez, D.
    Noor, Z.
    Callahan, R.
    Jones, B.
    Wong, D.
    Goldman, J. W.
    Applebaum, S.
    Rausch, R.
    Yanes, C.
    Bueno, S.
    Garban, N.
    Elashoff, D.
    Garon, E.
    Pietras, R.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S504 - S504
  • [7] Phase II Trial of Pemetrexed/Carboplatin/Bevacizumab plus /- Atezolizumab in NSCLC Patients That Are EGFR Mutated or Never Smoked
    Bodor, J. N.
    Patel, J.
    Ross, E.
    Litwin, S.
    Treat, J.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S404 - S404
  • [8] Pemetrexed-Carboplatin Versus Paclitaxel (Weekly)-Carboplatin as First Line Chemotherapy in Advanced Non-Squamous NSCLC
    Malik, P.
    Yadav, A.
    Jain, D.
    Pathy, S.
    Mohan, A.
    Khurana, S.
    Kumar, S.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S354 - S355
  • [9] RANDOMIZED STUDY OF PEMETREXED PLUS CARBOPLATIN FOLLOWED BY PEMETREXED VERSUS PACLITAXEL PLUS CARBOPLATIN FOLLOWED BY PEMETREXED IN NON-SQUAMOUS NSCLC (LOGIK0904)
    Moriwaki, Atsushi
    Inoue, Koji
    Takeshita, Masafumi
    Harada, Taishi
    Tashiro, Naoki
    Seto, Takashi
    Imanaga, Tomotoshi
    Fujimoto, Noriko
    Nakagaki, Noriaki
    Kawasaki, Masayuki
    Kishimoto, Junji
    Takayama, Koichi
    Ichinose, Yukito
    RESPIROLOGY, 2013, 18 : 27 - 27
  • [10] Anlotinib plus carboplatin/pemetrexed in treatment-naive advanced non-squamous NSCLC: An open-label, randomized, phase II study
    Guo, R.
    Gao, W.
    Li, J.
    Liu, Y.
    Liu, X.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) : S801 - S801
12345